Tracking Overdue For Follow-up
Mammologix's Overdue System has been developed for clients to make the process of tracking patients easier. These are communications created especially for your facility that can be shared with other health care providers, if needed. The purpose of Overdues is to notify you about any examinees being tracked that currently do have information pertaining the completion of Their recommended follow-up within a designated time period (Client specified time frame).
Overdues are available to both in an electronic format, via LogixDrive, a PDF Overdue Inquiry, and within the monthly Mammography Medical Outcome Audit (MMOA) provided by Mammologix. Use of the electronic Overdue System allows you to remain up-to-date with any examinee whose recommended follow-up information has not yet been made available.
Mammologix divides overdue patients into the following categories called Flags:
Overdues are available to both in an electronic format, via LogixDrive, a PDF Overdue Inquiry, and within the monthly Mammography Medical Outcome Audit (MMOA) provided by Mammologix. Use of the electronic Overdue System allows you to remain up-to-date with any examinee whose recommended follow-up information has not yet been made available.
Mammologix divides overdue patients into the following categories called Flags:
- Red Flag (Bi-Rads 4/5) - Overdue patients recommended a follow-up interventional procedure, such as a breast biopsy, aspiration, seed or needle localization, etc.
- Yellow Flag (Bi-Rads 0) - Overdue patients recommended some type of additional follow-up typically performed within the imaging suite, such as additional, views, breast ultrasound, MR, etc.
- White Flag (Bi-Rads 3) - Overdue patients recommended an early follow-up procedure required to complete the continuum of care from an initial exam, typically 4-6 months.
- Other Flag (Bi-Rads 3,4,5,6,) - Overdue patients whose recommendation for follow-up has past but does not fit within the typical overdue Red, Yellow, or White Flag categories described above.